2027 in pharma — approvals, patent cliffs, Phase 3 readouts

Every FDA approval, patent expiry, and pivotal Phase 3 readout tracked for 2027: 0 approvals, 176 patent expiries, 0 Phase 3 milestones.

20252026202720282029

FDA / EMA / MHRA approvals (0)

No entries tracked.

Patent expiries (176)

Phase 3 readouts (0)

No entries tracked.